Evidence map›Paper›PMID 36442910›Full record

ArticleBMJ case reports2022

Post-COVID mRNA vaccine myocarditis in children: report of two cases.

Ahmed Shamekh, Colin Powell, Abdusamea Ashabani, Ibtihal Siddiq Abdelgadir

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Ahmed ShamekhPaediatric Emergency, Sidra Medicine, Doha, Ad Dawhah, Qatar ashamekh@hotmail.com.
Colin PowellPaediatrics, Cardiff and Vale University Health Board, Cardiff, UK.
Abdusamea AshabaniPaediatric Emergency, Sidra Medicine, Doha, Ad Dawhah, Qatar.
Ibtihal Siddiq AbdelgadirPaediatric Emergency, Sidra Medical and Research Center, Doha, Qatar.ORCID http://orcid.org/0000-0002-8676-0953
Cardiff and Vale University Health Board · GBSidra Medical and Research Center · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SARS-COV-2 pandemic led to the development of several vaccinations to contain the disease. The Pfizer-BioNTech COVID-19 (BNT162b2) vaccine was recommended on May 2021 for use in children above 12 years and older. The vaccine is safe, well tolerated and highly effective. Initial reports showed no serious adverse events; however, cases of myocarditis in young healthy male adolescents have been reported. We report two cases of myocarditis/perimyocarditis who presented with short history of chest pain following administration of the second dose of the MRN COVID-19 vaccine.

Indexed as

BNT162 VaccineCOVID-19MyocarditisAdolescentChildHumansMaleSARS-CoV-2BNT162 VaccineCardiovascular systemCOVID-19Paediatrics (drugs and medicines)Vaccination/immunisation

Identifiers

PMID36442910
PMCPMC9710324
OpenAlexW4310086152

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.